High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials. (Q33945113)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

review article

1 reference

title

High-dose progestins for the treatment of cancer anorexia-cachexia syndrome: a systematic review of randomised clinical trials (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

Emanuela Scarpi

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

author name string

M Maltoni

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Rossi

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

P Serra

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

D Amadori

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

publication date

1 March 2001

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

volume

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

issue

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

page(s)

289-300

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group

7 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Nutrition in cancer patients: an update and review of our experience. Issues in symptom control. Part 3.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

The cancer anorexia-cachexia syndrome

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Cachectin/tumour-necrosis-factor production by cancer patients

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Prediction of survival of patients terminally ill with cancer. Results of an Italian prospective multicentric study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Parental nutrition: is it oncologically logical?

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Guidelines on artificial nutrition versus hydration in terminal cancer patients. European Association for Palliative Care

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Randomized comparison of megestrol acetate versus dexamethasone versus fluoxymesterone for the treatment of cancer anorexia/cachexia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

A controlled trial of cyproheptadine in cancer patients with anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Placebo-controlled trial of hydrazine sulfate in patients with newly diagnosed non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Influence of nandrolone decanoate on weight loss in advanced non-small cell lung cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Down-regulation of tumor necrosis factor expression by pentoxifylline in cancer patients: a pilot study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Thalidomide in patients with cachexia due to terminal cancer: preliminary report

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Randomized trial of low- versus high-dose medroxyprogesterone acetate in the induction treatment of postmenopausal patients with advanced breast cancer

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Cytokine involvement in cancer anorexia/cachexia: role of megestrol acetate and medroxyprogesterone acetate on cytokine downregulation and improvement of clinical symptoms

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Body-composition changes in patients who gain weight while receiving megestrol acetate

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Systematic literature review and meta-analysis

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Meta-analysis in clinical trials

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Meta-analysis in clinical research

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

A controlled trial of megestrol acetate on appetite, caloric intake, nutritional status, and other symptoms in patients with advanced cancer.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Megestrol acetate for anorexia in patients with far-advanced cancer: a double-blind controlled clinical trial

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Usefulness of megestrol acetate in cancer cachexia and anorexia. A placebo-controlled study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Risks and benefits of various therapies for cancer anorexia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Effects of medroxyprogesterone acetate on appetite, weight, and quality of life in advanced-stage non-hormone-sensitive cancer: a placebo-controlled multicenter study

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Anticachectic efficacy of megestrol acetate at different doses and versus placebo in patients with neoplastic cachexia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Improved quality of life with megestrol acetate in patients with endocrine-insensitive advanced cancer: a randomised placebo-controlled trial. Australasian Megestrol Acetate Cooperative Study Group.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

A double blind placebo controlled trial of medroxyprogesterone acetate (MPA) in cancer cachexia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Controlled trial of megestrol acetate for the treatment of cancer anorexia and cachexia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Randomized double-blind placebo-controlled trial of cisplatin and etoposide plus megestrol acetate/placebo in extensive-stage small-cell lung cancer: a North Central Cancer Treatment Group study.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Megestrol acetate in cancer anorexia and weight loss

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Megestrol acetate in advanced, progressive, hormone-insensitive cancer. Effects on the quality of life: a placebo-controlled, randomised, multicentre trial.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Methodologic issues in effectiveness research on palliative cancer care: a systematic review

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Placebo-controlled trials in palliative care: the argument against.

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

1 reference

7 January 2021

Phase III evaluation of four doses of megestrol acetate as therapy for patients with cancer anorexia and/or cachexia

1 reference

https://api.crossref.org/works/10.1023%2FA%3A1011156811739

7 January 2021

Identifiers

DOI

10.1023/A:1011156811739

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:11332139%20AND%20SRC:MED&resulttype=core&format=json

7 November 2019

1 reference